Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


22.03.2021

1 AIDS
2 Antimicrob Agents Chemother
2 Clin Infect Dis
4 Emerg Infect Dis
1 J Antimicrob Chemother
1 J Clin Microbiol
1 J Infect Dis
1 J Med Microbiol
1 J Virol
4 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. PANPRADIST N, Beck IA, Ruth PS, Avila-Rios S, et al
    Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort.
    AIDS. 2020 Mar 19. doi: 10.1097/QAD.0000000000002524.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  2. KARAU MJ, Schmidt-Malan SM, Mandrekar J, Lehoux D, et al
    Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.00117.
    PubMed         Abstract available

  3. MODLIN SJ, Marbach T, Werngren J, Mansjo M, et al
    Atypical Genetic Basis of Pyrazinamide Resistance in Mono-resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.01916.
    PubMed         Abstract available


    Clin Infect Dis

  4. JORGENSEN SCJ, Spellberg B, Shorr AF, Wright WF, et al
    Should Therapeutic Drug Monitoring Based on the Vancomycin Area Under the Concentration-Time Curve Be Standard for Serious Methicillin-Resistant Staphylococcus aureus Infections?-No.
    Clin Infect Dis. 2021 Mar 19. pii: 6178883. doi: 10.1093/cid/ciaa1743.
    PubMed         Abstract available

  5. LODISE TP, Drusano G
    Vancomycin Area Under the Curve-Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First.
    Clin Infect Dis. 2021 Mar 19. pii: 6178884. doi: 10.1093/cid/ciaa1744.
    PubMed         Abstract available


    Emerg Infect Dis

  6. GUAN Q, Almutairi TS, Alhalouli T, Pain A, et al
    Metagenomics of Imported Multidrug-Resistant Mycobacterium leprae, Saudi Arabia, 2017.
    Emerg Infect Dis. 2020;26:615-617.
    PubMed         Abstract available

  7. MERKER M, Nikolaevskaya E, Kohl TA, Molina-Moya B, et al
    Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Emerg Infect Dis. 2020;26:481-490.
    PubMed         Abstract available

  8. TOWN K, Harris S, Sanchez-Buso L, Cole MJ, et al
    Genomic and Phenotypic Variability in Neisseria gonorrhoeae Antimicrobial Susceptibility, England.
    Emerg Infect Dis. 2020;26:505-515.
    PubMed         Abstract available

  9. SHUAIB YA, Khalil EAG, Wieler LH, Schaible UE, et al
    Mycobacterium tuberculosis Complex Lineage 3 as Causative Agent of Pulmonary Tuberculosis, Eastern Sudan(1).
    Emerg Infect Dis. 2020;26:427-436.
    PubMed         Abstract available


    J Antimicrob Chemother

  10. HUANG HH, Wu BK, Li LH, Lin YT, et al
    Role of the PhoPQ two-component regulatory system in the beta-lactam resistance of Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2021 Mar 19. pii: 6178648. doi: 10.1093.
    PubMed         Abstract available


    J Clin Microbiol

  11. LE ROY C, Bebear C, Pereyre S
    Performance of Three Commercial Molecular Diagnostic Assays for the Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance.
    J Clin Microbiol. 2021 Mar 17. pii: JCM.00020-21. doi: 10.1128/JCM.00020.
    PubMed         Abstract available


    J Infect Dis

  12. JOHNSON MD, Lewis RE, Dodds Ashley ES, Ostrosky-Zeichner L, et al
    Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium.
    J Infect Dis. 2020;222.
    PubMed         Abstract available


    J Med Microbiol

  13. SHARMA S, Das A, Banerjee T, Barman H, et al
    Adaptations of carbapenem resistant Acinetobacter baumannii (CRAB) in the hospital environment causing sustained outbreak.
    J Med Microbiol. 2021 Mar 19. doi: 10.1099/jmm.0.001345.
    PubMed         Abstract available


    J Virol

  14. JEONG JH, Choi WS, Antigua KJC, Choi YK, et al
    In vitro profiling of laninamivir-resistant substitutions in N3 to N9 avian influenza neuraminidase subtypes and their association with in vivo susceptibility.
    J Virol. 2020 Oct 14. pii: JVI.01679-20. doi: 10.1128/JVI.01679.
    PubMed         Abstract available


    PLoS One

  15. SCHINDLER Y, Rahav G, Nissan I, Madar-Shapiro L, et al
    Group B Streptococcus serotypes associated with different clinical syndromes: Asymptomatic carriage in pregnant women, intrauterine fetal death, and early onset disease in the newborn.
    PLoS One. 2020;15:e0244450.
    PubMed         Abstract available

  16. MESTROVIC A, Perkovic N, Bozic J, Pavicic Ivelja M, et al
    Randomised clinical trial comparing concomitant and hybrid therapy for eradication of Helicobacter pylori infection.
    PLoS One. 2020;15:e0244500.
    PubMed         Abstract available

  17. KASOZI S, Kirirabwa NS, Kimuli D, Luwaga H, et al
    Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda.
    PLoS One. 2020;15:e0244451.
    PubMed         Abstract available

  18. PARAMITA RI, Nelwan EJ, Fadilah F, Renesteen E, et al
    Genome-based characterization of Escherichia coli causing bloodstream infection through next-generation sequencing.
    PLoS One. 2020;15:e0244358.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: